U.S. federal trademark · Serial No. 98947793 · Reg. No. 4306319
Medical and veterinary services; health services, namely, medical evaluation services for the purpose of guiding treatment; medical treatment services, namely, medical treatment of gut dysbiosis related diseases; digestive-system disease medical treatment services, namely, medical treatment of digestive-system diseases; medical services provided in the field of microbiotherapy; medical assistance; health counseling services; pharmacy advice, namely, pharmaceutical consultation; blood bank services; medical equipment rental; hospital services; nursing home services; pharmacists' services, namely, preparation of prescriptions by pharmacists; Medical therapeutic services, namely, therapeutic transplantation of gut to preserve the gut symbiosis; physiotherapy; telemedicine services, namely, virtual medical consultation about biomarkers used to characterize the gut microbiota
Consulting services in the field of engineering, namely, evaluations and assessments in the fields of science and technology provided by engineers; scientific research and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, metagenomics, metabolomics, transcriptomics, fluxomics and therapies meant to have an effect on the gut microbiota functions; scientific research services for medical purposes; research and development of new products for others; technical project studies, namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services, namely, laboratory research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; engineering in the nature of surveying work; engineering; scientific laboratory services; scientific research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy; scientific and technical research and analysis for the characterization of the genetics fingerprint of the human intestinal microbiota (Based on 44e); Providing online non-downloadable computer software for designing, identifying, monitoring and validating medical treatment of gut dysbiosis related diseases; Providing online non-downloadable computer software to monitor drug development and manufacturing; Providing online non-downloadable computer software to stratify patients for ulterior treatments; Providing online non-downloadable computer software to study diseases and identify biomarkers (Based on Intent-to Use)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.